While decreased NKILA expression levels in breast tumors are associated with metastasis and poor prognosis of breast cancer patients (Liu et al. 2015), NKILA has been more recently shown to be also critical for immune evasion of breast and lung cancer cells (Huang et al. 2018). Here, NKILA is linked to breast carcinoma.